Clinical Trial Update: SGLT2-inhibitors on PC-AKI

View source ↗

Summary

A clinical trial evaluating whether SGLT2 inhibitors influence the risk of post-contrast acute kidney injury in patients with acute coronary syndrome undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Kidney Injury
• Post-contrast Acute Kidney Injury

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy | Status: ACTIVE_NOT_RECRUITING